Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




External Cues Can Replace Genetic Manipulation for Cell Reprogramming

By LabMedica International staff writers
Posted on 19 Aug 2008
Cell biologists seeking to transform differentiated adult cells back to cells that resemble embryonic stem cells, have begun the process of replacing virally transmitted genes with environmentally supplied growth factors.

The current state-of-the art is to generate induced pluripotent (IPS) cells by reprogramming adult cells through the use of viruses to transfer four genes (Oct4, Sox2, c-Myc, and Klf4) into the cells' DNA. More...
This process is both inefficient and potentially dangerous in that the retroviruses used for gene transfer are potentially carcinogenic, and c-Myc is a known oncogene whose overexpression can also cause cancer.
In the current study, investigators at the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) left c-Myc out of the formula, replacing it with the protein-signaling molecule Wnt3a. Wnt3a was supplied as an additive to the cells' culture medium rather than as a product of gene transfer.

Results published in the August 6, 2008, online edition of the journal Cell Stem Cell revealed that Wnt3a was able to replace the c-Myc oncogene and, in conjunction with the other three transfected genes, induce the formation of IPS cells.

"IPS cells hold great potential for future medicine, but we must learn how to generate these cells in a manner that is safe for clinical therapies,” said contributing author Dr. Richard Young, professor of biology at MIT. "This advance in reprogramming is one key step toward that goal.”

The investigators concede that while these results mark a good start toward using external cues instead of genetic manipulation to reprogram cells, it is still necessary to eliminate the need for retroviruses for the three other genes.

Related Links:
Massachusetts Institute of Technology



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.